Our results demonstrated that decreased expression of PTPN12 was a prognostic factor in HCC patients with stage I/II or stage III/IV (P<0.05, Figure 3B and 3C, Kaplan-Meier method). Here, PTPN12 is linked to hepatocellular carcinoma.